Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Feinstein

Showing results (161-170 of 358) with videos related to

Pageof 36
Sort By:
The Yale Journal of Biology and Medicine|March 25, 2011
II. Treatment and PreventionM Spagnuolo, A R Feinstein
Archives of Internal Medicine|May 1, 1970
The changing emphasis in clinical research. 3. Follow-up report for the years 1965-1969A R Feinstein, N Koss
The American Journal of Medicine|January 16, 1998
Problems in the "evidence" of "evidence-based medicine"A R Feinstein, R I Horwitz
Clinical Pharmacology and Therapeutics|October 1, 1980
Clinical biostatistics. LIII. The architecture of observer/method variability and other types of process researchA R Feinstein, M S Kramer
The New England Journal of Medicine|November 16, 1978
Alternative analytic methods for case-control studies of estrogens and endometrial cancerR I Horwitz, A R Feinstein
Cancer Research|November 1, 1978
A critique of the statistical evidence associating estrogens with endometrial cancerA R Feinstein, R I Horwitz
Clinics in Chest Medicine|May 1, 1982
Lung cancer staging. A critical evaluationA R Feinstein, C K Wells
The Journal of Pediatrics|April 1, 1980
The steroid-croup controversy: an analytic review of methodologic problemsW W Tunnessen, A R Feinstein
JAMA|November 27, 1981
Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarctionR I Horwitz, A R Feinstein
JAMA|April 8, 1974
The auxometric dimension. A new method for using rate of growth in prognostic staging of breast cancerM E Charlson, A R Feinstein
Pageof 36

Showing results (161-170 of 358) with videos related to

Sort By:
Pageof 36
The Yale Journal of Biology and Medicine|March 25, 2011
II. Treatment and PreventionM Spagnuolo, A R Feinstein
Archives of Internal Medicine|May 1, 1970
The changing emphasis in clinical research. 3. Follow-up report for the years 1965-1969A R Feinstein, N Koss
The American Journal of Medicine|January 16, 1998
Problems in the "evidence" of "evidence-based medicine"A R Feinstein, R I Horwitz
Clinical Pharmacology and Therapeutics|October 1, 1980
Clinical biostatistics. LIII. The architecture of observer/method variability and other types of process researchA R Feinstein, M S Kramer
The New England Journal of Medicine|November 16, 1978
Alternative analytic methods for case-control studies of estrogens and endometrial cancerR I Horwitz, A R Feinstein
Cancer Research|November 1, 1978
A critique of the statistical evidence associating estrogens with endometrial cancerA R Feinstein, R I Horwitz
Clinics in Chest Medicine|May 1, 1982
Lung cancer staging. A critical evaluationA R Feinstein, C K Wells
The Journal of Pediatrics|April 1, 1980
The steroid-croup controversy: an analytic review of methodologic problemsW W Tunnessen, A R Feinstein
JAMA|November 27, 1981
Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarctionR I Horwitz, A R Feinstein
JAMA|April 8, 1974
The auxometric dimension. A new method for using rate of growth in prognostic staging of breast cancerM E Charlson, A R Feinstein
Pageof 36